Brixton was founded by Charles Sidoti.

Who are Brixton's investors?

Brixton's investors include Angel Physicians Fund, Excelestar Ventures, FemHealth Ventures, Schooner Capital, SV Health Investors.

Brixton

5 known investors

Find your way into Brixton

Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.

Biotech Medical Devices

Founders & leadership

Charles SidotiinFounderFounder at Brixtonbio

Investors · 5

Angel Physicians Fund

Excelestar VenturesAndover

FemHealth VenturesShort Hills

Schooner CapitalBoston

SV Health InvestorsBoston · $1M – $20M

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2022	$252.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Brixton do?: Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.
Who founded Brixton?: Brixton was founded by Charles Sidoti.
Who are Brixton's investors?: Brixton's investors include Angel Physicians Fund, Excelestar Ventures, FemHealth Ventures, Schooner Capital, SV Health Investors.